Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 6,652,000 | 6,594,000 | 6,238,000 | 6,846,000 | 6,706,000 |
| Cost of Goods | 1,588,000 | 1,510,000 | 1,561,000 | 1,718,000 | 1,609,000 |
| Gross Profit | 5,064,000 | 5,084,000 | 4,677,000 | 5,128,000 | 5,097,000 |
| Operating Expenses | 2,404,000 | 2,908,000 | 2,177,000 | 2,824,000 | 2,719,000 |
| Operating Income | 2,660,000 | 2,176,000 | 2,500,000 | 2,304,000 | 2,378,000 |
| Interest Expense | 368,000 | 328,000 | 295,000 | 335,000 | 296,000 |
| Other Income | 100,000 | -317,000 | -530,000 | 162,000 | 73,000 |
| Pre-tax Income | 2,392,000 | 1,531,000 | 1,675,000 | 2,131,000 | 2,155,000 |
| Income Tax | 249,000 | 214,000 | 199,000 | 232,000 | 271,000 |
| Net Income Continuous | 2,143,000 | 1,317,000 | 1,476,000 | 1,899,000 | 1,884,000 |
| Net Income | $2,143,000 | $1,317,000 | $1,476,000 | $1,899,000 | $1,884,000 |
| EPS Basic Total Ops | 4.01 | 2.46 | 2.69 | 3.36 | 3.32 |
| EPS Basic Continuous Ops | 4.01 | 2.46 | 2.69 | 3.35 | 3.32 |
| EPS Diluted Total Ops | 3.98 | 2.45 | 2.68 | 3.33 | 3.31 |
| EPS Diluted Continuous Ops | 3.98 | 2.45 | 2.68 | 3.34 | 3.31 |
| EPS Diluted Before Non-Recurring Items | 4.70 | 4.65 | 4.25 | N/A | N/A |
| EBITDA(a) | $3,497,000 | $3,004,000 | $3,341,000 | $3,156,000 | $3,228,000 |